Application 214489

Type
ANDA
Sponsor
LUPIN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AZILSARTAN MEDOXOMILAZILSARTAN MEDOXOMILTABLET; ORAL40MGNoNo
002AZILSARTAN MEDOXOMILAZILSARTAN MEDOXOMILTABLET; ORAL80MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A214489-001AZILSARTAN MEDOXOMILAZILSARTAN KAMEDOXOMILEQ 40MG MEDOXOMILTABLET / ORALAB2022-07-20
A214489-002AZILSARTAN MEDOXOMILAZILSARTAN KAMEDOXOMILEQ 80MG MEDOXOMILTABLET / ORALAB2022-07-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A214489-001AB
A214489-002AB

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
A214489-001PC2026-12-12
A214489-002PC2026-12-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 54 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-2031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-206a471c1ec25d…
2025-08-23 18:47 UTC2025-08A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-205bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20d06236e962d9…
2024-10-29 15:01 UTC2024-10A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-2079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-201e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-208072bd15b7f6…
2024-05-31 18:47 UTC2024-05A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-208072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-206a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-201c564ffb4f44…
2024-02-18 07:12 UTC2024-02A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-209b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A214489-001AZILSARTAN MEDOXOMILEQ 40MG MEDOXOMILTABLET / ORAL2022-07-20a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A214489-002AZILSARTAN MEDOXOMILEQ 80MG MEDOXOMILTABLET / ORAL2022-07-20a67488948f0b…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A214489-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A214489-002AB1a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A214489-001PC2026-12-12a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A214489-002PC2026-12-12a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Azilsartan medoxomilAZILSARTAN MEDOXOMILLupin Pharmaceuticals, Inc.b1c8de43-3b26-408f-8c7e-6c7d763481992026-05-13Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 214489
application number: ANDA214489

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
69860ORIG2022-01-12